0000899243-21-027891.txt : 20210708
0000899243-21-027891.hdr.sgml : 20210708
20210708172131
ACCESSION NUMBER: 0000899243-21-027891
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210706
FILED AS OF DATE: 20210708
DATE AS OF CHANGE: 20210708
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sands Capital Ventures Discovery Fund III, L.P.
CENTRAL INDEX KEY: 0001870491
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40551
FILM NUMBER: 211081003
BUSINESS ADDRESS:
STREET 1: C/O SANDS CAPITAL VENTURES, LLC
STREET 2: 1000 WILSON BOULEVARD, SUITE 3000
CITY: ARLINGTON
STATE: VA
ZIP: 22209
BUSINESS PHONE: 703-562-4000
MAIL ADDRESS:
STREET 1: C/O SANDS CAPITAL VENTURES, LLC
STREET 2: 1000 WILSON BOULEVARD, SUITE 3000
CITY: ARLINGTON
STATE: VA
ZIP: 22209
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sands Capital Life Sciences Pulse Fund, LLC
CENTRAL INDEX KEY: 0001870490
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40551
FILM NUMBER: 211081001
BUSINESS ADDRESS:
STREET 1: C/O SANDS CAPITAL VENTURES, LLC
STREET 2: 1000 WILSON BOULEVARD, SUITE 3000
CITY: ARLINGTON
STATE: VA
ZIP: 22209
BUSINESS PHONE: 703-562-4000
MAIL ADDRESS:
STREET 1: C/O SANDS CAPITAL VENTURES, LLC
STREET 2: 1000 WILSON BOULEVARD, SUITE 3000
CITY: ARLINGTON
STATE: VA
ZIP: 22209
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SANDS FRANK M.
CENTRAL INDEX KEY: 0001870494
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40551
FILM NUMBER: 211081000
MAIL ADDRESS:
STREET 1: 100 WILSON BLVD
STREET 2: SUITE 3000
CITY: ARLINGTON
STATE: VA
ZIP: 22209
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sands Capital Global Venture Fund II, L.P.
CENTRAL INDEX KEY: 0001870493
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40551
FILM NUMBER: 211081002
BUSINESS ADDRESS:
STREET 1: C/O SANDS CAPITAL VENTURES, LLC
STREET 2: 1000 WILSON BOULEVARD, SUITE 3000
CITY: ARLINGTON
STATE: VA
ZIP: 22209
BUSINESS PHONE: 703-562-4000
MAIL ADDRESS:
STREET 1: C/O SANDS CAPITAL VENTURES, LLC
STREET 2: 1000 WILSON BOULEVARD, SUITE 3000
CITY: ARLINGTON
STATE: VA
ZIP: 22209
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Acumen Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001576885
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 364108129
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4435 NORTH FIRST STREET, SUITE 360
CITY: LIVERMORE
STATE: CA
ZIP: 94551
BUSINESS PHONE: 925-368-8508
MAIL ADDRESS:
STREET 1: 4435 NORTH FIRST STREET, SUITE 360
CITY: LIVERMORE
STATE: CA
ZIP: 94551
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-07-06
1
0001576885
Acumen Pharmaceuticals, Inc.
ABOS
0001870491
Sands Capital Ventures Discovery Fund III, L.P.
1000 WILSON BLVD., SUITE 3000
ARLINGTON
VA
22209
0
0
1
0
0001870493
Sands Capital Global Venture Fund II, L.P.
1000 WILSON BLVD, SUITE 3000
ARLINGTON
VA
22209
0
0
1
0
0001870490
Sands Capital Life Sciences Pulse Fund, LLC
1000 WILSON BLVD, SUITE 3000
ARLINGTON
VA
22209
0
0
1
0
0001870494
SANDS FRANK M.
1000 WILSON BLVD, SUITE 3000
ARLINGTON
VA
22209
0
0
1
0
Common Stock
2021-07-06
4
C
0
1124729
A
1124729
D
Common Stock
2021-07-06
4
C
0
1842346
A
2967075
D
Common Stock
2021-07-06
4
P
0
450000
14.88
A
3417075
D
Series A-1 Preferred Stock
2021-07-06
4
C
0
1124729
D
Common Stock
1124729
0
D
Series B Preferred Stock
2021-07-06
4
C
0
1842346
D
Common Stock
1842346
0
D
Each share of Series A-1 Preferred Stock and each share of Series B Preferred Stock automatically converted into one share of Common Stock of the Issuer upon the closing of the Issuer's initial public offering.
Represents 225,000 shares of Common Stock acquired by Sands Capital Global Venture Fund II, L.P. ("Sands Venture Fund") and 225,000 shares of Common Stock acquired by ands Capital Life Sciences Pulse Fund ("Sands Pulse Fund") in connection with the closing of the Issuer's initial public offering.
Consists of 1,124,719 shares of Common Stock held by Sands Capital Ventures Discovery Fund III, L.P. ("Sands Discovery Fund "). Sands Capital Ventures Discovery Fund III-GP, LLC ("Sands Discovery GP") is the general partner of Sands Discovery Fund. Sands Discovery GP disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
Consists of 921,173 shares of Common Stock held by Sands Venture Fund and 921,173 shares of Common Stock held by Sands Pulse Fund. Sands Capital Global Venture Fund II-GP, L.P. ("Sands Venture GP L.P.") is the general partner of Sands Venture Fund and Sands Capital Global Venture Discovery Fund II-GP, LLC ("Sands Venture GP LLC") is the general partner of Sands Venture GP L.P. Sands Venture GP L.P. and Sands Venture GP LLC each disclaims beneficial ownership of such securities except to the extent of its respective pecuniary interest therein.
Frank M. Sands holds ultimate voting and investment power over securities held by Sands Discovery Fund, Sands Venture Fund and Sands Pulse Fund. Mr. Sands disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
/s/ Jonathan Goodman, General Counsel of Sands Capital Ventures Discovery Fund III-GP, LLC, the General Partner of Sands Capital Ventures Discovery Fund III, L.P.
2021-07-08
/s/ Jonathan Goodman, General Counsel of Sands Capital Global Venture Discovery Fund II-GP, LLC, the General Partner of Sands Capital Global Venture Fund II-GP, L.P., the General Partner of Sands Capital Venture Fund II, L.P.
2021-07-08
/s/ Jonathan Goodman, General Counsel of Sands Capital Life Sciences Pulse Fund, LLC
2021-07-08
/s/ Frank M. Sands
2021-07-08